Who
Jeffrey L. Edwards
Director
Company insider
Files Form 4 as: Director, Kyntra Bio; Director, Bio-Rad Laboratories; Director, Lifecore Biomedical; Director, Clearside Biomedical; EVP, Fin & Bus. Dev., CFO, Allergan.
In numbers
- Trades disclosed
- 161
- Buys
- 0
- Sells
- 17
- Bought
- $0
- Sold
- $64.0M
- Companies
- 5
- Companies where not an officer
- 4
- First trade
- 6 Feb 2006
- Last trade
- 12 Jun 2026
- Last filed
- 17 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 12 Jun 2026filed 17 Jun 2026 | KYNB Kyntra Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —7,000 at $0.00 | filing |
| 12 Jun 2026filed 17 Jun 2026 | KYNB Kyntra Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —7,000 at $0.00 | filing |
| 21 Apr 2026filed 23 Apr 2026 | BIO Bio-Rad LaboratoriesLife-science tools | SEC FORM 4 Code M | —407 at $0.00 | filing |
| 21 Apr 2026filed 23 Apr 2026 | BIO Bio-Rad Laboratoriesoption or derivative · Life-science tools | SEC FORM 4 Code A | —369 at $0.00 | filing |
| 21 Apr 2026filed 23 Apr 2026 | BIO Bio-Rad Laboratoriesoption or derivative · Life-science tools | SEC FORM 4 Code M | —407 at $0.00 | filing |
| 21 Apr 2026filed 23 Apr 2026 | BIO Bio-Rad Laboratoriesoption or derivative · Life-science tools | SEC FORM 4 Code A | —369 at $0.00 | filing |
| 21 Apr 2026filed 23 Apr 2026 | BIO Bio-Rad Laboratoriesoption or derivative · Life-science tools | SEC FORM 4 Code M | —407 at $0.00 | filing |
| 21 Apr 2026filed 23 Apr 2026 | BIO Bio-Rad LaboratoriesLife-science tools | SEC FORM 4 Code M | —407 at $0.00 | filing |
| 4 Jun 2025filed 6 Jun 2025 | KYNB Kyntra Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —120,000 at $0.00 | filing |
| 22 Apr 2025filed 24 Apr 2025 | BIO Bio-Rad Laboratoriesoption or derivative · Life-science tools | SEC FORM 4 Code A | —407 at $0.00 | filing |
| 22 Apr 2025filed 24 Apr 2025 | BIO Bio-Rad Laboratoriesoption or derivative · Life-science tools | SEC FORM 4 Code M | —308 at $0.00 | filing |
| 22 Apr 2025filed 24 Apr 2025 | BIO Bio-Rad LaboratoriesLife-science tools | SEC FORM 4 Code M | —308 at $0.00 | filing |
| 6 Sep 2024filed 10 Sep 2024 | BIO Bio-Rad Laboratoriesoption or derivative · Life-science tools | SEC FORM 4 Code A | —308 at $0.00 | filing |
| 8 Jul 2024filed 10 Jul 2024 | LFCR Lifecore BiomedicalBiotechnology | SEC FORM 4 Code A | —30,000 | filing |
| 20 Jun 2024filed 21 Jun 2024 | Clearside Biomedicaloption or derivative | SEC FORM 4 Code A | —45,000 at $0.00 | filing |
| 5 Jun 2024filed 6 Jun 2024 | KYNB Kyntra Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —70,000 at $0.00 | filing |
| 1 Feb 2024filed 2 Feb 2024 | LFCR Lifecore Biomedicaloption or derivative · Biotechnology | SEC FORM 4 Code M | —9,554 at $0.00 | filing |
| 1 Feb 2024filed 2 Feb 2024 | LFCR Lifecore BiomedicalBiotechnology | SEC FORM 4 Code M | —9,554 | filing |
| 22 Jun 2023filed 23 Jun 2023 | Clearside Biomedicaloption or derivative | SEC FORM 4 Code A | —30,000 at $0.00 | filing |
| 9 Jun 2023filed 9 Jun 2023 | KYNB Kyntra BioBiotechnology | SEC FORM 4 Sold | $55K3,265 at $16.74 | filing |
News
Kyntra Bio Inc (KYNB) – What Are Brokerages Saying About This Stock?KYNB · dailypolitical.com · 14 Oct 2026Prothena (NASDAQ:PRTA) vs. Kyntra Bio (NASDAQ:KYNB) Financial ReviewKYNB · dailypolitical.com · 12 Oct 2026Head to Head Review: Kyntra Bio (NASDAQ:KYNB) and Q32 Bio (NASDAQ:QTTB)KYNB · tickerreport.com · 12 Oct 2026
0 headlines in the last 90 days name Jeffrey L. Edwards; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.
Sectors
Related people
Nobody else traded the same names lately.